Trajan Group Holdings Ltd (ASX: TRJ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Trajan Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Trajan Group Holdings Ltd (ASX: TRJ)
Latest News
Healthcare Shares
3 ASX health care shares that outpaced the market on Friday
Share Gainers
The Trajan (ASX:TRJ) share price is up 38% in under two weeks
TRJ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Trajan Group Holdings Ltd
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
TRJ Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
14 Nov 2024 | $1.13 | $-0.03 | -2.59% | 37,156 | $1.13 | $1.14 | $1.13 |
13 Nov 2024 | $1.16 | $0.03 | 2.65% | 19,432 | $1.13 | $1.16 | $1.13 |
12 Nov 2024 | $1.13 | $-0.05 | -4.24% | 9,777 | $1.15 | $1.15 | $1.13 |
11 Nov 2024 | $1.18 | $0.01 | 0.85% | 598 | $1.17 | $1.19 | $1.17 |
08 Nov 2024 | $1.17 | $-0.03 | -2.50% | 1,881 | $1.18 | $1.18 | $1.17 |
07 Nov 2024 | $1.20 | $0.00 | 0.00% | 38,004 | $1.20 | $1.26 | $1.20 |
06 Nov 2024 | $1.20 | $0.04 | 3.46% | 3,000 | $1.20 | $1.20 | $1.20 |
05 Nov 2024 | $1.16 | $0.01 | 0.87% | 163 | $1.15 | $1.16 | $1.15 |
04 Nov 2024 | $1.15 | $-0.08 | -6.50% | 4,500 | $1.15 | $1.15 | $1.15 |
01 Nov 2024 | $1.23 | $-0.03 | -2.38% | 11,500 | $1.25 | $1.25 | $1.23 |
30 Oct 2024 | $1.26 | $0.00 | 0.00% | 6,264 | $1.26 | $1.26 | $1.25 |
29 Oct 2024 | $1.26 | $0.06 | 5.00% | 116,898 | $1.20 | $1.26 | $1.20 |
28 Oct 2024 | $1.20 | $-0.01 | -0.83% | 2,533 | $1.20 | $1.20 | $1.20 |
25 Oct 2024 | $1.21 | $0.01 | 0.83% | 10,453 | $1.15 | $1.21 | $1.15 |
23 Oct 2024 | $1.20 | $0.00 | 0.00% | 5,635 | $1.19 | $1.20 | $1.19 |
22 Oct 2024 | $1.20 | $0.00 | 0.00% | 16,065 | $1.19 | $1.20 | $1.18 |
21 Oct 2024 | $1.20 | $-0.02 | -1.64% | 11,383 | $1.22 | $1.22 | $1.20 |
18 Oct 2024 | $1.22 | $0.00 | 0.00% | 810 | $1.22 | $1.22 | $1.22 |
17 Oct 2024 | $1.22 | $0.01 | 0.83% | 72,093 | $1.20 | $1.22 | $1.19 |
16 Oct 2024 | $1.21 | $-0.03 | -2.43% | 18,175 | $1.24 | $1.24 | $1.17 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
02 Sep 2024 | John Eales | Buy | 44,206 | $53,047 |
Exercise of options.
|
02 Sep 2024 | John Eales | Exercise | 44,206 | $53,047 |
Exercise of options.
|
21 May 2024 | John Eales | Buy | 200,000 | $198,408 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Robert (Bob) John Lyon | Head of Corporate Development and General CounselExecutive Director | Sep 2014 |
Mr Lyon has global responsibility for the strategic growth of Trajan's business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan's industry, academic, government and research partners in the scientific and medical sectors globally. As Trajan's General Counsel he also has responsibility for the negotiation and execution of Trajan's investments and transactions, as well as for its legal requirements. Prior to joining Trajan, Robert had a 15-year career in law including as a partner at Page Seager Lawyers before spending six years with KPMG Corporate Finance.
|
Mr John Anthony Eales | Non-Executive ChairmanNon-Executive Director | Mar 2021 |
Mr Eales has served as an executive, adviser, director and investor in a number of listed public companies and unlisted private organisations. John co-founded the Mettle Group in 2003, a corporate consultancy which was acquired by Chandler Macleod in 2007. He is the Chair of the World Rugby Hall of Fame Selection Panel and was on the Rugby Australia Bid Advisory Board for the Rugby World Cup 2027. He is a Patron of the Melanoma Foundation, Hearts in Union and the Champagnat Trust. Other current publicly listed company directorships: Non- Executive Director of Flight Centre Travel Group and Magellan Financial Group. He is member of risk committee.
|
Ms Sara Elizabeth Watts | Non-Executive Director | Mar 2021 |
Ms Watts is an experienced Non-Executive Director with financial and operational experience across more than 20 years in a range of industries including technology, education, NFP and resources. Sara's previous executive positions include Chief Financial Officer of IBM Australia/New Zealand, Head of Internal Audit for IBM Asia Pacific and Vice Principal (Operations) at the University of Sydney. She is chair of Risk Committee.
|
Mr Rohit Khanna | Non-Executive Director | Mar 2021 |
Mr Khanna has over 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, Dr Khanna co-founded Dynamic Solutions, a software-engineering firm dedicated to providing solutions to the scientific and engineering community. Dr Khanna went on to hold senior management roles at Waters Corporation, including Vice-President and General Manager of the Data Products Group. In 2002, Dr Khanna was appointed Vice-President, Worldwide Marketing, and recently Dr Khanna was Senior Vice President of several key Waters Corporation businesses including Informatics, Service, and Chemistry, along with being a member of the Corporate Executive Committee. Dr. Khanna retired from Waters in 2017 and continues to work with industry leaders and on several Industry Boards. He is Member of the Risk Committee.
|
Mr Stephen Andrew Tomisich | Chief Executive OfficerManaging Director | Aug 2011 |
Mr Tomisich is responsible for the design and implementation of Trajan's strategic business plan and overall leadership of the organisation.
|
Ms Tiffiny Jane Lewin | Non-Executive Director | Mar 2021 |
Ms Lewin brings operational, risk and strategy expertise gained over a 30-year career spanning consumer goods, manufacturing, professional services and the finance sectors. Tiffiny is currently a leader at Westpac Group where she has served since 2015. Prior to Westpac, Tiffiny held leadership, operational and strategy roles across Australia and Asia for global organisations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble where she delivered organisational transformation, performance turnaround and market growth across business and consumer sectors. She is member of Risk Committee.
|
Mr Mark Andrew Licciardo | Joint Company Secretary | Jun 2021 |
-
|
Mr Alister John Hodges | Chief Financial OfficerJoint Company Secretary | Jun 2021 |
-
|
Alister John Hodges | Chief Financial OfficerJoint Company Secretary |
-
|
|
Nigel Gilligan | Chief Operations Officer |
-
|
|
Andrew Gooley | Chief Scientific Officer |
-
|
|
Mark Andrew Licciardo | Joint Company Secretary |
-
|
|
Sam Evans | Senior Vice President Business Development |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Tomisich Family Pty Ltd | 76,833,745 | 50.48% |
J P Morgan Nominees Australia Pty Limited | 13,691,141 | 8.99% |
HSBC Custody Nominees (Australia) Limited | 12,775,823 | 8.39% |
Citicorp Nominees Pty Limited | 11,542,715 | 7.58% |
Farrona Llc | 4,659,843 | 3.06% |
Telunapa Pty Ltd <Telunapa Capital A/C> | 1,552,075 | 1.02% |
Ruck & Maul Pty Ltd <The John Eales Family A/C> | 1,151,553 | 0.76% |
BNP Paribas Noms Pty Ltd | 867,706 | 0.57% |
Mr Alister John Hodges | 700,000 | 0.46% |
Investment Holdings Pty Ltd <Investment Holdings Unit A/C> | 615,000 | 0.40% |
Mutual Trust Pty Ltd | 533,055 | 0.35% |
Redbrook Nominees Pty Ltd | 450,000 | 0.30% |
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 429,537 | 0.28% |
Invia Custodian Pty Limited <Mj Sherwin Family A/C> | 350,000 | 0.23% |
Investment Society One Pty Ltd <Investment Society One A/C> | 330,248 | 0.22% |
Devonport Central Pty Ltd <Chas & Robyn Kelly Fam A/C> | 319,856 | 0.21% |
Lyon Super Fund Pty Ltd <Lyon Family Super Fund A/C> | 316,470 | 0.21% |
Prineas Super Pty Ltd <Prineas Super Fund A/C> | 300,000 | 0.20% |
Jummysue Pty Ltd <Scurry Superannuation A/C> | 288,000 | 0.19% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 264,821 | 0.17% |